Opendata, web and dolomites

IRIS-1

IRIS Feasibility Study – Phase 1

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 IRIS-1 project word cloud

Explore the words cloud of the IRIS-1 project. It provides you a very rough idea of what is the project "IRIS-1" about.

overwhelming    post    respiratory    disabilities    rely    customised    healthcare    predict    surpassing    public    reduce    burden    data    economic    financial    personalised    dynamic    annually    period    limitations    generate    fraction    morbidities    physiological    calculations    monitoring    worldwide    severity    accepted    intervals    hundreds    recognition    re    dimensional    survive    stage    renal    alarms    failures    successful    care    innovative    thresholds    scoring    outcome    solely    amount    interactions    iris    sensitive    surgery    staff    arbitrary    operative    millions    thousands    feasibility    heart    euros    chance    hospital    time    identification    risk    suitability    patient    rates    assist    medical    adaptive    trust    complications    intervention    serious    introduction    patients    mortality    incorporating    sustainability    rinicare    admission    prediction    continuous    die    clinical    health    lack    volumes    individual    detect    human    prompt    intensive   

Project "IRIS-1" data sheet

The following table provides information about the project.

Coordinator
RINICARE LIMITED 

Organization address
address: RIVERWAY HOUSE MORECAMBE ROAD
city: LANCASTER
postcode: LA1 2RX
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://rinicare.com/randd/rinicare/rinicare-stability/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RINICARE LIMITED UK (LANCASTER) coordinator 50˙000.00

Map

 Project objective

The IRIS Feasibility Study – Phase 1 (IRIS-1) Project aims to assess the overall feasibility of the introduction of the Intensive-care Risk prediction and Identification System (IRIS), an innovative real-time patient monitoring and personalised risk prediction and identification system, into the healthcare sector. Thousands of surgery patients in Europe and worldwide die each year due to complications during the post- operative period and thousands more survive with disabilities, making the economic burden of post-operative complications in surgery patients amount to hundreds of millions of euros annually. It is widely accepted that early recognition of complications can reduce their severity and consequences: continuous patient monitoring systems and risk scoring systems are available but they lack suitability for patients in intensive care, trust calculations at time intervals, analyse solely a fraction of available patient data, cannot detect multi-dimensional trends, rely on arbitrary thresholds to generate alarms and cannot be customised for each patient. Thus, there are increased mortality rates and re-admission rates to hospital, contributing to the overwhelming financial and economic burden of public healthcare. Addressing serious morbidities, such as heart, renal and respiratory failures, and capable of surpassing human limitations in processing large volumes of patient data, IRIS is a real-time adaptive and dynamic patient monitoring and risk prediction and identification system, sensitive to variable interactions and capable of incorporating patient data to identify trends in individual patients’ physiological parameters that predict post- operative complications. Developed by RINICARE, IRIS will assist clinical staff to identify at an early stage serious complications in surgery patients, allowing a prompt medical intervention, thus improving the chance of a successful health outcome and contributing to the sustainability of the healthcare system.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IRIS-1" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IRIS-1" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More